Quarterly report [Sections 13 or 15(d)]

CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited)

v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS' EQUITY (Unaudited) - USD ($)
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Treasury Stock, Common [Member]
Total
Beginning balance, value at Dec. 31, 2024 $ 1,804 $ 1,545 $ 208,225,748 $ (197,194,471) $ 253,734 $ (5,281,180) $ 6,007,180
Beginning balance, shares at Dec. 31, 2024 1,804,394 1,544,840          
Share-based expense 34,934 34,934
Net loss (1,591,844) (1,591,844)
Ending balance, value at Jun. 30, 2025 $ 1,804 $ 1,545 208,260,682 (198,786,315) 253,734 (5,281,180) 4,450,270
Ending balance, shares at Jun. 30, 2025 1,804,394 1,544,840          
Beginning balance, value at Mar. 31, 2025 $ 1,804 $ 1,545 208,244,999 (198,097,612) 253,734 (5,281,180) 5,123,290
Beginning balance, shares at Mar. 31, 2025 1,804,394 1,544,840          
Share-based expense 15,683 15,683
Net loss (688,703) (688,703)
Ending balance, value at Jun. 30, 2025 $ 1,804 $ 1,545 208,260,682 (198,786,315) 253,734 (5,281,180) 4,450,270
Ending balance, shares at Jun. 30, 2025 1,804,394 1,544,840          
Beginning balance, value at Dec. 31, 2025 $ 1,454 $ 2,294 212,294,851 (199,875,331) 253,734 (5,281,180) 7,395,822
Beginning balance, shares at Dec. 31, 2025 1,454,545 2,293,757          
Issuance of common stock in connection with restricted stock $ 7 (7)
Issuance of common stock in connection with restricted stock, shares   7,000          
Conversion of Series B Preferred Stock to common stock $ (1,454) $ 45 1,409
Conversion of Series B Preferred Stock to common stock, shares (1,454,545)            
Conversion of Series B Preferred Stock to common stock, shares   45,125          
Share-based expense 63,276 63,276
Net loss (1,386,077) (1,386,077)
Ending balance, value at Jun. 30, 2026 $ 2,346 212,359,529 (201,261,408) 253,734 (5,281,180) 6,073,021
Ending balance, shares at Jun. 30, 2026 0 2,345,882          
Beginning balance, value at Mar. 31, 2026 $ 1,454 $ 2,294 212,306,163 (200,331,713) 253,734 (5,281,180) 6,950,752
Beginning balance, shares at Mar. 31, 2026 1,454,545 2,293,757          
Issuance of common stock in connection with restricted stock $ 7 (7)
Issuance of common stock in connection with restricted stock, shares   7,000          
Conversion of Series B Preferred Stock to common stock $ (1,454) $ 45 1,409
Conversion of Series B Preferred Stock to common stock, shares (1,454,545)            
Conversion of Series B Preferred Stock to common stock, shares   45,125          
Share-based expense 51,964 51,964
Net loss (929,695) (929,695)
Ending balance, value at Jun. 30, 2026 $ 2,346 $ 212,359,529 $ (201,261,408) $ 253,734 $ (5,281,180) $ 6,073,021
Ending balance, shares at Jun. 30, 2026 0 2,345,882